Uterine lavage for the detection of ovarian cancer using an expanded gene panelTalayeh Ghezelayagh, Barbara M. Norquist, Jeanne Fredrickson et al.|Gynecologic Oncology|2021Cited by 1
Evaluation of TP53 mutations in Pap test and blood DNA as novel biomarkers of ovarian cancer riskTalayeh Ghezelayagh, Rosana Risques, Jeanne Fredrickson et al.|Gynecologic Oncology|2021Cited by 0
Evaluation of TP53 mutations in Pap test and blood DNA as novel biomarkers of ovarian cancer riskTalayeh Ghezelayagh, Rosana Risques, Jeanne Fredrickson et al.|Gynecologic Oncology|2021Cited by 0
Uterine lavage for the detection of ovarian cancer using an expanded gene panelTalayeh Ghezelayagh, Barbara M. Norquist, Jeanne Fredrickson et al.|Gynecologic Oncology|2021Cited by 0
TP53 mutations in Pap test DNA are a potential biomarker of ovarian cancer risk in high-risk women (226)Talayeh Ghezelayagh, Rosana Risques, Jeanne Fredrickson et al.|Gynecologic Oncology|2022Cited by 0